Skip to main content
Journal cover image

Sustained British Isles Lupus Assessment Group-Measured Improvement In Moderately-and-Severely Affected Body Systems In Patients With Systemic Lupus Erythematosus By Epratuzumab: Results From An Open-Label Extension Study

Publication ,  Conference
Kalunian, K; Clowse, MEB; Houssiau, F; Petri, MA; Kilgallen, B; Gordon, C; Strand, V; Bongardt, S; Wallace, DJ
Published in: ARTHRITIS AND RHEUMATISM
October 1, 2013

Duke Scholars

Published In

ARTHRITIS AND RHEUMATISM

EISSN

1529-0131

ISSN

0004-3591

Publication Date

October 1, 2013

Volume

65

Start / End Page

S738 / S738

Location

San Diego, CA

Publisher

WILEY-BLACKWELL

Conference Name

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals

Related Subject Headings

  • Arthritis & Rheumatology
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kalunian, K., Clowse, M. E. B., Houssiau, F., Petri, M. A., Kilgallen, B., Gordon, C., … Wallace, D. J. (2013). Sustained British Isles Lupus Assessment Group-Measured Improvement In Moderately-and-Severely Affected Body Systems In Patients With Systemic Lupus Erythematosus By Epratuzumab: Results From An Open-Label Extension Study. In ARTHRITIS AND RHEUMATISM (Vol. 65, pp. S738–S738). San Diego, CA: WILEY-BLACKWELL.
Kalunian, Kenneth, Megan E. B. Clowse, Frederic Houssiau, Michelle A. Petri, Brian Kilgallen, Caroline Gordon, Vibeke Strand, Sabine Bongardt, and Daniel J. Wallace. “Sustained British Isles Lupus Assessment Group-Measured Improvement In Moderately-and-Severely Affected Body Systems In Patients With Systemic Lupus Erythematosus By Epratuzumab: Results From An Open-Label Extension Study.” In ARTHRITIS AND RHEUMATISM, 65:S738–S738. WILEY-BLACKWELL, 2013.
Kalunian K, Clowse MEB, Houssiau F, Petri MA, Kilgallen B, Gordon C, Strand V, Bongardt S, Wallace DJ. Sustained British Isles Lupus Assessment Group-Measured Improvement In Moderately-and-Severely Affected Body Systems In Patients With Systemic Lupus Erythematosus By Epratuzumab: Results From An Open-Label Extension Study. ARTHRITIS AND RHEUMATISM. WILEY-BLACKWELL; 2013. p. S738–S738.
Journal cover image

Published In

ARTHRITIS AND RHEUMATISM

EISSN

1529-0131

ISSN

0004-3591

Publication Date

October 1, 2013

Volume

65

Start / End Page

S738 / S738

Location

San Diego, CA

Publisher

WILEY-BLACKWELL

Conference Name

77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals

Related Subject Headings

  • Arthritis & Rheumatology
  • 1117 Public Health and Health Services
  • 1107 Immunology
  • 1103 Clinical Sciences